Understanding Spravato
What is Spravato? Spravato (esketamine) is a groundbreaking medication for adults with treatment-resistant depression (TRD). Approved by the FDA in 2019, it offers a novel approach for individuals who have not found relief with traditional antidepressants. Unlike standard treatments, Spravato is administered as a nasal...